Evidence-based Decision-making on Antimicrobial Resistance

UNDP South-South|Galaxy Knowledge Hub

Evidence-based Decision-making on Antimicrobial Resistance

Latin American quality control programme in Bacteriology and Antimicrobial Drug Resistance

Challenges

Antimicrobial resistance (AMR) affects all countries and endangers the effectiveness of prevention and treatment of infections by viruses, bacteria, fungi and parasites. Antimicrobial resistance occurs when microorganisms (e.g. bacteria, fungi, viruses and parasites) change when they are exposed to antimicrobial drugs (e.g. antibiotics, antifungals, antivirals, antimalarials and anthelmintics). Microorganisms that develop antimicrobial resistance are sometimes referred to as ‘superbugs’. Asaresult, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others. AMR is an increasingly serious threat to global public health that requires action across all government sectors and society. It is estimated that 10 per cent of all patients who receive hospital care develop a healthcare-associated infection. In recent years, the Latin America and the Caribbean region experienced a series of outbreaks caused by multi-drug resistant bacteria, impacting lives and hospital costs.

Toward a Solution

Since the 1990s, Pan American Health Organization/World Health Organization (PAHO/ WHO) has recognized the importance of laboratory capacity for AMR surveillance and created the Latin American Antimicrobial Resistance Surveillance Network (ReLAVRA) in 1996 to obtain reliable microbiological data and timely and repeatable information to improve patient care and strengthen surveillance through sustainable quality assurance programmes.

This Network, which was built by Argentina, the Plurinational State of Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, the Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, and the Bolivarian Republic of Venezuela, established the Latin American Quality Control Programme in Bacteriology and Antimicrobial Drug Resistance (LA-EQAS), implemented by the Antimicrobial Department of the Instituto Nacional de Enfermedades Infecciosas (INEI) in Argentina. The latter has a dual function: to ensure the quality of surveillance data and to strengthen the countries’ reference laboratories.

LA-EQAS is fundamental in terms of achieving reliable laboratory data, which are the basis of AMR surveillance. Through this initiative, data quality is ensured by standardizing techniques so that the entire region ‘speaks the same language’ and the countries can compare and share solutions. AMR data contributes to reducing infant and maternal mortality, improving population health, and fighting curable and preventable diseases through the use of safe and affordable antimicrobials for all.

LA-EQAS has strengthened the laboratories of the countries of the Network through training courses, generating reference strains, defining resistance mechanisms, issuing publications and holding online sessions with the countries of the Network.

The success of this horizontal cooperation among countries and in triangulation with PAHO/WHO is based on continuity over time, commitment of the health authorities, financial support from seed and resources from PAHO/WHO and the laboratories of the countries, as well as the great leadership and solidary of the INEI of ANLIS-Argentina.

CONTACT INFORMATION
Country and Subregional Coordination Office, Pan American Health Organization (PAHO/WHO)

SDG
03 - Good Health and Well-being

SUPPORTED BY
Pan American Health Organization (PAHO/WHO)

ABOUT

Disclosures

RESOURCES

Disclosures

ENGAGE

Disclosures

Alliance Application Form

Submit an Expression of Interest and/or Demand Signal. UNOSSC reviews submissions on a rolling basis.

1. Official name of organization / institution / government entity (exclusions to apply) *

2. Country *

3. Region *

4. SDG *

Secondary SDG *

5. Partner category *

6. Website *

7. Brief description of your institution (max. 150 words) *

Name for the Lead *

Title for the Lead *

Email address for the Lead *

Name for the co-lead

Title for the co-lead

Email address for the co-lead

Section 3. Expression of Interest in the Alliance *

Offer expertise, resources, partnership, or collaboration

Demand Signal (Request for cooperation, support, or partnership)

Both (Offering capabilities and expressing demand for collaboration)

Additional information on proposed areas of engagement may be requested through the platform following initial review by the Alliance Secretariat.

Section 4. Due Diligence and Integrity Declaration *

Our organization complies with United Nations values, principles, and ethical standards.

We are not subject to UN sanctions or listed on applicable UN exclusion or ineligibility lists.

We understand that participation in Alliance activities may be subject to due diligence conducted by the Alliance Secretariat, consistent with applicable UN policies.

We acknowledge that engagement under the Alliance does not imply formal membership.

Submission Note:

Submission of this Expression of Interest form does not automatically confer participation in the Alliance.

All submissions will be reviewed by the Alliance Secretariat, including basic eligibility screening and proportionate due diligence, as appropriate.

Participation in Alliance activities is determined based on relevance to articulated cooperation needs, alignment with Alliance principles, and integrity considerations.

Engagement under the Alliance is voluntary, non-binding, and facilitative in nature, and does not constitute funding approval, contractual commitment, or institutional membership.

The Alliance Secretariat may contact submitting entities for additional information or clarification during the review process.

Organization Registration

Authentication & Due Diligence This prototype simulates identity verification, due diligence confirmation, and an authentication step before submission. *

Due diligence declarationWe confirm compliance with UN values, ethical standards, and we are not subject to sanctions/exclusion lists.

First Name *

Last Name *

Email address *

Password *

Confirm Password *

Name of institution / organization *

Country / Region *

Organization Type *

Organization other *

Function / role *

Organization logo *

Maximum file size: 1 GB

I confirm this information is accurate and I agree to be contacted about network participation. *